Tag: Q3 FY26

ORIENTTECH – Orient Technologies – Q4 FY26 Financial Results – 27-May-26

Orient Tech’s FY26 shows near‑zero PAT, negative FCF, rising debt, and Services margin compression. Strategic pivot to Services is valid, but cost controls must improve. Re‑rating hinges on Services margin >22%, two quarters of positive OCF, and clarity on ₹2,368L exceptional charge/other current assets.

1–2 minutes

🔍 Observations

Topline

  • Services segment (IT Infra & Application Services) grew 33% YoY (₹33,510 → ₹44,656 lakhs), now the larger segment; partially offset Solutions decline of 17% (₹50,443 → ₹41,837 lakhs), delivering muted 3% consolidated revenue growth (₹83,953 → ₹86,493 lakhs).
  • Q4FY26 revenue collapsed 30% YoY (₹26,068 → ₹18,133 lakhs) — sharpest quarterly dip in the dataset, signalling either client concentration risk or deal timing issues in the Solutions segment.
  • Other income fell 15% YoY (₹676 → ₹573 lakhs), removing a cushion that propped up PBT in prior years.

Bottomline

  • PAT imploded 94.5% YoY (₹5,044 → ₹279 lakhs) on a full-year basis; Q4 and Q3 both reported net losses, making H2FY26 entirely loss-making at the PAT level.
  • Exceptional items of ₹2,368 lakhs (FY26) versus nil (FY25) are the swing factor — pre-exceptional PBT fell 58% (₹6,802 → ₹2,876 lakhs), itself a severe deterioration before adjusting for one-offs.
  • EPS collapsed from ₹11.01 to ₹0.61, erasing almost the entire per-share earnings base in a single year.

Margins

  • Gross margin (Revenue minus COGS per segment data) compressed: Solutions gross margin ~10.4% (FY26) vs ~9.5% (FY25) — marginal improvement; Services gross margin ~19.8% (FY26) vs ~26.8% (FY25) — severe 700bps compression, the primary P&L destroyer.
  • Operating expense inflation outside COGS is structural: employee costs +17% (₹4,862 → ₹5,688 lakhs), other expenses +55% (₹2,143 → ₹3,317 lakhs), depreciation +167% (₹512 → ₹1,365 lakhs), finance costs +321% (₹122 → ₹512 lakhs) — all four cost lines inflating simultaneously.
  • Pre-exceptional EBIT margin compressed from ~8.1% (FY25) to ~3.3% (FY26); net margin from 6.0% to 0.3%.

Growth Trajectory

  • The business mix shift toward Services (now 51.6% of revenue vs 39.9% in FY25) is strategically sound but execution has deteriorated sharply — Services segment results fell marginally (₹8,991 → ₹8,850 lakhs) despite 33% revenue growth, implying cost overruns absorbed the topline gain.
  • Unallocated corporate expenses grew 1.6% YoY (₹6,330 → ₹6,431 lakhs) — relatively contained, but at 7.4% of revenue they represent a heavy fixed cost anchor for a low-margin IT distributor.
  • Capital employed has grown significantly (capex of ₹6,288 lakhs vs ₹2,554 lakhs in FY25; PPE nearly 3.5x from ₹2,069 → ₹7,259 lakhs) without commensurate revenue or profit scale-up — returns on incremental capital are poor at this juncture.
Continue reading “ORIENTTECH – Orient Technologies – Q4 FY26 Financial Results – 27-May-26”

ORIENTTECH – Q3 FY26 Earnings Call – 19-Feb-26

ORIENTTECH’s topline growth hinges on annuity mix execution (NOC/SOC, government contracts) and hardware recovery timing; bottom-line leverage requires margin normalization post-FY26 contract resets, with AI tailwinds as upside optionalities.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Supply chain normalizes by late FY27; NOC/SOC hits 70% utilization by FY28.
Outcome: Revenue grows 12–15% CAGR to ₹850–900 crore FY27, with EBITDA margins recovering to 7–9% on services mix improvement. EPS ₹2.50–3.00 as government/pharma contracts scale.

Continue reading “ORIENTTECH – Q3 FY26 Earnings Call – 19-Feb-26”

MUTHOOTFIN – Q3 FY26 Earnings Call – 12-Feb-26

MUTHOOTFIN: Gold loan structural tailwinds and regulatory support underpin 18–22% AUM growth, but earnings quality hinges on NPA recovery sustainability and opex discipline; margins face 50–100 bps compression if cost inflation outpaces revenue, while competitive and macro risks cap upside to low-teens EPS growth.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Gold prices stable (±5%), MCLR pass-through in H2, regulated branch growth.
Outcome: AUM grows 18–22%, NIM stable at ~7.5% (recoveries offset funding lag). Opex growth moderates to 15%, margins 26–28%. EPS grows 8–12%, driven by gold loan dominance and subsidiary turnarounds. Guidance clarity supports valuation rerating.

Continue reading “MUTHOOTFIN – Q3 FY26 Earnings Call – 12-Feb-26”

ZYDUSLIFE – Q3 FY26 Earnings Call – 10-Feb-26

ZYDUSLIFE’s topline: 12–15% CAGR driven by US specialty, India chronic portfolio, and International Markets; Bottomline: 8–10% EPS growth contingent on margin stability and R&D efficiency; Margins: 23–25% EBITDA range, with upside from biosimilar scaling and downside from acquisition dilution.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

  • Key Variables: Mirabegron settlement; CDMO revenue ramp-up in H2 FY27; biosimilar launches on schedule.
  • Outcome: US revenue grows 8–10% YoY, driven by specialty and generics volume. EBITDA margins stabilize at 23–25%. India and International Markets sustain 15–20% growth. Net debt reduces to ₹2,500Cr by FY28 as cash flows improve. GLP-1 captures 10–15% market share in India.
Continue reading “ZYDUSLIFE – Q3 FY26 Earnings Call – 10-Feb-26”

DIVISLAB – Q3 FY26 Earnings Call – 11-Feb-26

DIVISLAB’s growth relies on CS (57% mix), with generics resilient but pressured by pricing. Bottomline depends on CS commercialization (CY27) and cost pass-through, while margins face labor/raw material volatility, partly offset by backward integration and automation over 2–3 years.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: (1) 2/3 CS projects commercialize in Q3–Q4 CY27; (2) Generic pricing stabilizes (China’s rebate removal lifts API prices by 3–5%). Outcome: Revenue 8–10% CAGR, EBITDA margins expand 50 bps (CS mix shift), and gross asset turnover improves to 1.4x by FY28. EPS grows 8–12% annually.

Continue reading “DIVISLAB – Q3 FY26 Earnings Call – 11-Feb-26”

TITAGARH – Q3 FY26 Earnings Call – 16-Feb-26

Passenger rail to drive 70%+ growth (18–25% CAGR), while freight lags; high-speed rail and MRVC remain wildcards. TITAGARH’s EBITDA margins could reach 13–15% by FY’28 with backward integration, but freight volatility and execution risks loom. Passenger scale and aluminium integration are margin-critical; freight stable yet input-sensitive.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

  • Key Variables: Freight tenders materialize in Q1 FY’27 (800–1,000 wagons/month); metro production hits 18–20 cars/month by FY’27; 1–2 high-speed rail contracts secured.
  • Outcome: Revenue CAGR of 18–22%, with Passenger Rail Systems contributing 60%+ of EBITDA by FY’28. Margins expand to 13–14% as backward integration kicks in; shipbuilding IPO adds INR1,000–1,500 crore valuation upside.
Continue reading “TITAGARH – Q3 FY26 Earnings Call – 16-Feb-26”

MAZDOCK – Q3 FY26 Earnings Call – 10-Feb-26

MAZDOCK’s topline: Structural defense tailwinds and order book visibility support 8–12% revenue CAGR, but execution risks cap upside; bottomline: EBITDA margins likely range-bound at 16–18% barring supply chain shocks; dividends: Sustainable at current payout ratios but vulnerable to capex trade-offs for next-gen projects.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: (1) P17A/MPV deliveries on schedule; (2) MOD budget grows at 8–10% annually.
Outcome: Revenue CAGR of 8–10%, margins stable at 16–18%. Dividend growth tracks earnings (₹8–10/share annually). FX neutrality assumed.

Continue reading “MAZDOCK – Q3 FY26 Earnings Call – 10-Feb-26”

INDHOTEL – Q3 FY26 Earnings Call – 12-Feb-26

INDHOTEL: Findings imply sustained double-digit topline growth (12%–14%) with EBITDA margins at 39%–40% and PAT expansion (15%–18%), contingent on RevPAR resilience, acquisition execution, and capex discipline—structural diversification and asset-light scaling remain key differentiators.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

  • RevPAR Resilience: 8.5%–10% domestic RevPAR + 12%–14% consolidated revenue growth (60+ openings, F&B/spa upside). Taj Bandstand on track for ₹1,000 crore stabilization.
  • Acquisition Synergies: Ginger reaches 250+ hotels; Atmantan/Brij contribute ₹250–300 crore. EBITDA margin sustains at 39%–40%.
  • Implication: Double-digit PAT growth (15%–18%), management fee income grows high-teens, and capital-light model drives ROIC expansion.
Continue reading “INDHOTEL – Q3 FY26 Earnings Call – 12-Feb-26”

BBOX – Q3 FY26 Earnings Call – 12-Feb-26

BBOX’s FY26 growth slows to 8–10% on execution risks, with FY27 rebound tied to supply chain recovery and $300–350M orders. Margins hold at 9–10% EBITDA, with upside to 10%+ hinging on annuity mix shift, inorganic accretion, and charge abatement.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Supply chain normalizes by H2 FY27, enabling $800M backlog conversion at 80% rate. 2S delivers INR45 crore EBITDA; enterprise revenue grows 12–15%. Outcome: FY27 revenue INR7,200 crore (13% YoY); EBITDA margins expand to 9.5%. Trigger: Stable hyperscaler demand and successful Brazil cross-selling.

Continue reading “BBOX – Q3 FY26 Earnings Call – 12-Feb-26”

FINCABLES – Q3 FY26 Earnings Call – 12-Feb-26

FINCABLES’ topline growth hinges on solar/fiber structural demand and government program execution, while margins face cyclical copper risks and structural competition—expect 11–12% EBIT as the new normal. Bottomline resilience depends on cash flow discipline and auto/solar capacity utilization.

1–2 minutes

3-Scenario Framework

📊 Base Case (50% Probability)

Key Variables: Copper stabilizes at 13,500 INR, fiber demand sustains, gradual Birla ramp-up.

  • Topline: 15–18% YoY growth driven by solar/fiber; OFC revenue hits INR 500–600 crore.
  • Margins: 11–12% EBIT as auto/solar volumes offset wire compression.
  • Cash Flow: FCF INR 200–250 crore, supporting reinvestment in E-Beam/auto capacity.
Continue reading “FINCABLES – Q3 FY26 Earnings Call – 12-Feb-26”